Physician profile
David Michael Tehrani
NPI 1851771158
$17,041.93
in general payments reported to CMS, 2019-2025
16 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $13.82 · 2021: $377 · 2022: $12K · 2023: $1,732 · 2024: $1,045 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,829.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,698.80 | 2021-2025 | Venaseal, Ffrangio |
| Edwards Lifesciences Corporation | $2,353.79 | 2022-2025 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $1,705.85 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,048.81 | 2022-2025 | Impella |
| Abbott Laboratories | $1,010.79 | 2019-2025 | Perclose Prostyle, Aveir, Pressurewire |
| Boston Scientific Corporation | $677.70 | 2022-2025 | Watchman Flx, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.41 | 2024-2025 | Lifevest |
| Pfizer INC. | $125.00 | 2019 | |
| Philips North America LLC | $92.30 | 2022 | |
| Heartflow, INC. | $50.00 | 2021 | |
| Cardiva Medical, INC. | $48.50 | 2025 | Optowire, Savvywire |
| Cardiac Dimensions, INC. | $32.12 | 2024 | |
| Lantheus Medical Imaging, INC. | $31.32 | 2019-2020 | |
| Cardiovascular Systems INC. | $18.72 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.82 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tehrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.